Patient Stories

Surviving to See the Milestones of Life

 

One woman’s story of a partial response from metastatic cervical cancer in a clinical trial with axalimogene filolisbac, Advaxis’ lead product candidate for HPV-related cancers. Axalimogene filolisbac is an investigational drug. These patient results may not be typical. Further study is warranted and is underway.

A Return to Active Life after Immunotherapy and Surgery

A 48-year-old man recovers from Head and Neck cancer through participation in a clinical trial using axalimogene filolisbac. Axalimogene filolisbac is an investigational drug. These patient results may not be typical. Further study is warranted and is underway.